BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25590559)

  • 21. DNA replication licensing factor Cdc6 and Plk4 kinase antagonistically regulate centrosome duplication via Sas-6.
    Xu X; Huang S; Zhang B; Huang F; Chi W; Fu J; Wang G; Li S; Jiang Q; Zhang C
    Nat Commun; 2017 Apr; 8():15164. PubMed ID: 28447620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability.
    Holland AJ; Lan W; Niessen S; Hoover H; Cleveland DW
    J Cell Biol; 2010 Jan; 188(2):191-8. PubMed ID: 20100909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal development, growth control, and homeostasis in the face of centrosome amplification.
    Kulukian A; Holland AJ; Vitre B; Naik S; Cleveland DW; Fuchs E
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6311-20. PubMed ID: 26578791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
    Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
    Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleophosmin/B23 activates Aurora A at the centrosome through phosphorylation of serine 89.
    Reboutier D; Troadec MB; Cremet JY; Fukasawa K; Prigent C
    J Cell Biol; 2012 Apr; 197(1):19-26. PubMed ID: 22451695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plk4 trans-autophosphorylation regulates centriole number by controlling betaTrCP-mediated degradation.
    Guderian G; Westendorf J; Uldschmid A; Nigg EA
    J Cell Sci; 2010 Jul; 123(Pt 13):2163-9. PubMed ID: 20516151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis.
    Holland AJ; Fachinetti D; Da Cruz S; Zhu Q; Vitre B; Lince-Faria M; Chen D; Parish N; Verma IM; Bettencourt-Dias M; Cleveland DW
    Mol Biol Cell; 2012 May; 23(10):1838-45. PubMed ID: 22456511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse.
    Coelho PA; Bury L; Shahbazi MN; Liakath-Ali K; Tate PH; Wormald S; Hindley CJ; Huch M; Archer J; Skarnes WC; Zernicka-Goetz M; Glover DM
    Open Biol; 2015 Dec; 5(12):150209. PubMed ID: 26701933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4.
    Cunha-Ferreira I; Rodrigues-Martins A; Bento I; Riparbelli M; Zhang W; Laue E; Callaini G; Glover DM; Bettencourt-Dias M
    Curr Biol; 2009 Jan; 19(1):43-9. PubMed ID: 19084407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centriole duplication: A lesson in self-control.
    Holland AJ; Lan W; Cleveland DW
    Cell Cycle; 2010 Jul; 9(14):2731-6. PubMed ID: 20647763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53, cyclin-dependent kinase and abnormal amplification of centrosomes.
    Fukasawa K
    Biochim Biophys Acta; 2008 Sep; 1786(1):15-23. PubMed ID: 18472015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PLK4: a promising target for cancer therapy.
    Zhao Y; Wang X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for polo-like kinase 4 in mediation of cytokinesis.
    Press MF; Xie B; Davenport S; Zhou Y; Guzman R; Nolan GP; O'Brien N; Palazzolo M; Mak TW; Brugge JS; Slamon DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11309-11318. PubMed ID: 31097597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification.
    Fournier M; Orpinell M; Grauffel C; Scheer E; Garnier JM; Ye T; Chavant V; Joint M; Esashi F; Dejaegere A; Gönczy P; Tora L
    Nat Commun; 2016 Oct; 7():13227. PubMed ID: 27796307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
    Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
    Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts.
    Morettin A; Ward A; Nantais J; Hudson JW
    BMC Genomics; 2009 Jul; 10():319. PubMed ID: 19607708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Menendez JA
    Cell Cycle; 2011 Apr; 10(8):1295-302. PubMed ID: 21474997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged overexpression of PLK4 leads to formation of centriole rosette clusters that are connected via canonical centrosome linker proteins.
    Ozcan SC; Kalkan BM; Cicek E; Canbaz AA; Acilan C
    Sci Rep; 2024 Feb; 14(1):4370. PubMed ID: 38388511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Protein Phosphatase 2A regulatory subunit Twins stabilizes Plk4 to induce centriole amplification.
    Brownlee CW; Klebba JE; Buster DW; Rogers GC
    J Cell Biol; 2011 Oct; 195(2):231-43. PubMed ID: 21987638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.
    Kanai M; Crowe MS; Zheng Y; Vande Woude GF; Fukasawa K
    Oncogene; 2010 Nov; 29(45):6040-50. PubMed ID: 20697357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.